SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

National Instruments Corp. – ‘8-K’ for 1/31/23 – ‘EX-99.1’

On:  Tuesday, 1/31/23, at 4:01pm ET   ·   For:  1/31/23   ·   Accession #:  935494-23-4   ·   File #:  1-41595

Previous ‘8-K’:  ‘8-K’ on / for 1/13/23   ·   Next:  ‘8-K’ on / for 3/3/23   ·   Latest:  ‘8-K’ on 10/18/23 for 10/13/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 1/31/23  National Instruments Corp.        8-K:2,8,9   1/31/23   11:879K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report -- form_8k                           HTML     25K 
 2: EX-99.1     Miscellaneous Exhibit -- exhibit99_1                HTML    693K 
 6: R1          Document and Entity Information                     HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 7: XML         XBRL Instance -- form_8k_htm                         XML     14K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- nati-20230131_lab                     XML     63K 
 5: EX-101.PRE  XBRL Presentations -- nati-20230131_pre              XML     45K 
 3: EX-101.SCH  XBRL Schema -- nati-20230131                         XSD     14K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               13±    19K 
11: ZIP         XBRL Zipped Folder -- 0000935494-23-000004-xbrl      Zip     49K 


‘EX-99.1’   —   Miscellaneous Exhibit — exhibit99_1


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 
 Contact: Marissa Vidaurri
Vice President of Investor Relations
(512) 683-5215

NI Achieves Record Revenue for Q4 and Fiscal Year 2022
Company’s transformation continues to deliver improved operating performance

Q4 2022 Highlights
All-time record revenue of $448 million, up 7 percent year over year
Q4 GAAP operating margin of 13 percent; Q4 non-GAAP operating margin of 25 percent
Strong diluted GAAP EPS of $0.30; all-time record diluted non-GAAP EPS of $0.63
Cash and cash equivalents of $140 million as of December 31, 2022

AUSTIN, Texas - January 31, 2023 - National Instruments Corporation (Nasdaq: NATI) today announced Q4 2022 revenue of $448 million, up 7 percent year over year and an all-time quarterly record.

In Q4 2022, the value of the company’s total orders was down 3 percent year over year. Geographic order growth for Q4 2022 compared with Q4 2021 was down 7 percent in the Americas, down 9 percent in APAC and up 7 percent in EMEA.

In Q4, GAAP gross margin was 68 percent and non-GAAP gross margin was 70 percent. Total Q4 GAAP operating expenses were $244 million, down 1 percent year over year. Total Q4 non-GAAP operating expenses were $201 million, down 6 percent year over year. GAAP operating margin was 13 percent in Q4, with GAAP operating income of $60 million, up 21 percent year over year. Non-GAAP operating margin was 25 percent in Q4, with non-GAAP operating income of $112 million, up 16 percent year over year.

GAAP net income for Q4 was $40 million, with diluted earnings per share ("EPS") of $0.30, and non-GAAP net income was $83 million, with non-GAAP diluted EPS of $0.63.

“2022 was a strong year as we continued to make strides in transforming NI into a higher-growth, more profitable, and more resilient company. Despite ongoing global macroeconomic uncertainty, we delivered on the 2022 targets we shared at our September investor conference with record revenue of $1.7 billion, up 13 percent YOY, and non-GAAP operating margin of 20 percent, up 130 bps as compared to 2021," said Eric Starkloff, NI president and CEO. “As we head into 2023, even in a recessionary environment, we now expect to exceed our 300 bps non-GAAP margin expansion target.”

“In my first few weeks at NI, I've been impressed with the high level of talent in the organization, as well as the NI culture of engineering and commitment to its customers,” said Daniel Berenbaum, NI CFO. “My focus will be on accelerating operational improvements to achieve our margin targets, improving working capital management and cash flow generation, and building investor confidence in our ability to execute. We have already undertaken a number of initiatives which underpin our confidence in being able to generate significant operating margin improvement in 2023.”

NI’s non-GAAP results exclude, as applicable, the impact of purchase accounting fair value adjustments, stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange gain/loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings/assets and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of NI’s GAAP and non-GAAP results are included as part of this news release.
FY 2022 Highlights

All-time record revenue of $1.66 billion, up 13 percent year over year
GAAP operating margin of 12 percent; Non-GAAP operating margin of 20 percent
Strong diluted GAAP EPS of $1.05; record diluted non-GAAP EPS of $1.93
Returned $300 million to stockholders through dividends and stock repurchases

In 2022, GAAP operating expenses were $964 million, up 4 percent year over year, and non-GAAP operating expenses were $836 million, up 1 percent year over year. GAAP net income in 2022 was $140 million, up 56 percent year over year, and non-GAAP net income was $255 million, up 14 percent year over year.

As of December 31, 2022, NI had $140 million in cash with $43 million in cash generated from operations in 2022. During Q4, NI paid $37 million in dividends. For the year, we returned $300 million to our stockholders through dividends and stock repurchases, including the repurchase of 3.8 million shares at an average price of $40.04 per share. The NI Board of Directors approved a dividend of $0.28 per share payable on March 6, 2023, to stockholders of record at the close of business on February 13, 2023.
Q1 2023 Guidance
GAAP revenue to be in the range of $415 million to $445 million, up 12 percent year over year at the midpoint
GAAP diluted EPS to be in the range of $0.14 to $0.28, up 2 cents year over year at the midpoint
Non-GAAP diluted EPS expected to be in the range of $0.48 to $0.62, up 34 percent year over year at the midpoint

Conference Call Information
Today, NI management will host a call with the investment community to discuss the company's financial performance in the fourth quarter. Investors can listen to the Q4 2022 earnings conference call beginning at 4:00 p.m. CT today. This event will be webcast in listen-only mode. Listeners may log on to the call at www.ni.com/investor-relations under the “Events and Presentations” section and select “Q4 2022 NATI Earnings Conference Call” to participate. The webcast will remain on the company site for 90 days.

Non-GAAP Presentation
To supplement NI’s financial statements presented on a GAAP basis, NI has provided non-GAAP financial information, including non-GAAP revenue or net sales, gross profit, gross margin, operating expenses, operating income, operating margin, provision for income taxes, net income, net margin and diluted EPS and non-GAAP guidance for diluted EPS. A reconciliation of the adjustments to GAAP results is included in the tables below. Additionally, certain non-GAAP financial measures presented on a forward-looking basis, such as non-GAAP operating margin, were not reconciled to the comparable GAAP financial measures because the reconciliation could not be performed without unreasonable efforts due to the unpredictability of the amounts and timing of events affecting the items we exclude from non-GAAP measures. Non-GAAP financial information is not meant as a substitute for GAAP results, but is included because management believes such information is useful to our investors for informational and comparative purposes. In addition, certain non-GAAP financial information is used internally by management to evaluate and manage the company. The non-GAAP financial information used by NI may differ from that used by other companies. These non-GAAP measures should be considered in addition to, and not as a substitute for, the results prepared in accordance with GAAP.

Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 including without limitation those statements about our expectations of accelerating growth and progress to meet or exceed our financial targets and long-term financial model, our continued momentum across regions and business units, our opportunities to drive growth, profitability and efficiency in our business, confidence in our strategy and the strategic changes made to our business, our ability to successfully integrate acquisitions and execute our growth strategy, our ability to turn backlog to revenue, our ability to drive customer demand through focus on high growth opportunities, the impacts of war in Europe, supply chain constraints and software licensing model transition on our financial results, the outcome of the Company’s restructuring activities and strategic alternatives process and our guidance and expectations for our Q1 2023 revenue, diluted EPS and non-GAAP diluted EPS, and future operating expenses, backlog, lead times, gross margin, operating margin and tax rate. These statements are subject to a number of risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the global shortage of key components; effect of the global economic and geopolitical conditions; our international operations and foreign economies; adverse public health matters, including epidemics and pandemics such as the COVID-19 pandemic; our ability to effectively manage our partners and distribution channels; interruptions in our technology systems or cyber-attacks on our systems; the dependency of our product revenue on certain industries and the risk of contractions in such industries; concentration of credit risk and uncertain conditions in the global financial markets; our ability to compete in markets that are highly competitive; our ability to release successful new products or achieve expected returns; the risk that our manufacturing capacity and a substantial majority of our warehousing and distribution capacity are located outside of the U.S.; our dependence on key suppliers and distributors; longer delivery lead times from our suppliers; risk of product liability claims; dependence on our proprietary rights and risks of intellectual property litigation; the continued service of key management, technical personnel and operational employees; our ability to comply with environmental laws and associated costs; our ability to maintain our website; the risks of bugs, vulnerabilities, errors or design flaws in our products; our restructuring activities; our exposure to large orders; our shift to more system orders; our ability to effectively manage our operating expenses and meet budget; fluctuations in our quarterly results due to factors outside of our control; our outstanding debt; the interest rate risk associated with our variable rate indebtedness; seasonal variation in our revenues; our ability to comply with laws and regulations; changes in tax rates and exposure to additional tax liabilities; our ability to make certain acquisitions or dispositions, integrate the companies we acquire or separate the companies we sold and/or enter into strategic relationships; risks related to currency fluctuations; provisions in charter documents and Delaware law that delay or prevent our acquisition; and risks related to our strategic review process. In addition, our ability to declare and/or pay declared dividends is subject to compliance with the terms of our existing credit agreement. The company directs readers to its Form 10-K for the year ended December 31, 2021, its subsequent Form 10-Qs, and the other documents it files with the SEC for other risks associated with the company’s future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements. All information in this release is as of the date above. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.

About NI
At NI, we bring together people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day.

National Instruments, NI, ni.com and Engineer Ambitiously are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies. (NATI-F)

National Instruments
 
Condensed Consolidated Balance Sheets
 
(in thousands)
 
 
 
December 31,
     
 
     
2021
 
 
 
(unaudited)
       
ASSETS
           
Current assets:
           
Cash and cash equivalents
 
$
139,799
   
$
211,106
 
Accounts receivable, net
   
445,279
     
341,275
 
Inventories, net
   
388,164
     
289,243
 
Prepaid expenses and other current assets
   
115,677
     
89,925
 
Total current assets
   
1,088,919
     
931,549
 
Property and equipment, net
   
265,380
     
253,668
 
Goodwill
   
615,734
     
575,992
 
Intangible assets, net
   
200,850
     
220,418
 
Operating lease right-of-use assets
   
59,176
     
58,641
 
Other long-term assets
   
128,479
     
74,717
 
Total assets
   
2,358,538
     
2,114,985
 
 
               
LIABILITIES AND EQUITY
               
Current liabilities:
               
Accounts payable (1)
   
54,639
     
59,063
 
Accrued compensation
   
71,422
     
111,261
 
Deferred revenue
   
137,208
     
137,818
 
Operating lease liabilities
   
13,834
     
13,137
 
Other taxes payable
   
67,615
     
59,109
 
Debt - current
   
25,000
     
 
Accrued expenses and other current liabilities (1)
   
153,157
     
64,826
 
Total current liabilities
   
522,875
     
445,214
 
Debt - non-current
   
516,637
     
300,000
 
Deferred income taxes
   
1,676
     
14,249
 
Income tax payable - non-current
   
40,646
     
54,195
 
Deferred revenue - non-current
   
63,066
     
32,822
 
Operating lease liabilities - non-current
   
30,588
     
30,468
 
Other long-term liabilities
   
26,926
     
14,340
 
Total liabilities
   
1,202,414
     
891,288
 
 
               
Stockholders' equity:
               
Preferred stock
   
     
 
Common stock
   
1,310
     
1,323
 
Additional paid-in capital
   
1,207,420
     
1,129,647
 
Retained (deficit) earnings
   
(14,741
)
   
112,858
 
Accumulated other comprehensive loss
   
(37,865
)
   
(20,131
)
Total stockholders' equity
   
1,156,124
     
1,223,697
 
Total liabilities and stockholders' equity
 
$
2,358,538
   
$
2,114,985
 

(1): In the fourth quarter 2022, we reclassified $26.9 million of accrued liability balances from “Accounts payable” to “Accrued expenses and other current liabilities.”  To conform with the current period presentation, the following amounts reported in previous periods have also been reclassified: $25.6 million at September 30, 2022, $29.8 million at June 30, 2022, $23.2 million at March 31, 2022, and $24.2 million at December 31, 2021.



National Instruments
 
Condensed Consolidated Statements of Income
 
(in thousands, except per share data, unaudited)
 
 
                 
 
 
Three Months Ended
   
Years Ended
 
 
 
December 31,
     
 
     
2021
   
2022
   
2021
 
 
                       
Net sales:
                       
Product
 
$
412,607
   
$
377,303
   
$
1,500,716
   
$
1,304,609
 
Software maintenance
   
35,669
     
43,338
     
156,259
     
165,072
 
Total net sales
   
448,276
     
420,641
     
1,656,975
     
1,469,681
 
 
                               
Cost of sales:
                               
Product
   
139,700
     
119,857
     
517,854
     
406,342
 
Software maintenance
   
4,621
     
3,739
     
16,870
     
14,621
 
Total cost of sales
   
144,321
     
123,596
     
534,724
     
420,963
 
 
                               
Gross profit
   
303,955
     
297,045
     
1,122,251
     
1,048,718
 
 
   
68%

   
71%

   
68%

   
71%

Operating expenses:
                               
Sales and marketing
   
118,252
     
122,304
     
483,267
     
467,352
 
Research and development
   
81,100
     
92,301
     
331,710
     
335,986
 
General and administrative
   
44,272
     
32,543
     
148,841
     
127,215
 
Total operating expenses
   
243,624
     
247,148
     
963,818
     
930,553
 
Gain on sale of assets
   
     
     
33,636
     
 
Operating income
   
60,331
     
49,897
     
192,069
     
118,165
 
Other income (expense)
   
(11,571
)
   
(4,739
)
   
(20,193
)
   
(14,590
)
Income before income taxes
   
48,760
     
45,158
     
171,876
     
103,575
 
Provision for income taxes
   
8,694
     
4,822
     
32,232
     
14,260
 
Net income
 
$
40,066
   
$
40,336
   
$
139,644
   
$
89,315
 
                                 
Basic earnings per share
 
$
0.31
   
$
0.31
   
$
1.06
   
$
0.68
 
Diluted earnings per share
 
$
0.30
   
$
0.30
   
$
1.05
   
$
0.67
 
 
                               
Weighted average shares outstanding -
                               
Basic
   
130,842
     
132,215
     
131,738
     
132,311
 
Diluted
   
131,746
     
133,225
     
132,533
     
133,562
 
 
                               
Dividends declared per share
 
$
0.28
   
$
0.27
   
$
1.12
   
$
1.08
 


National Instruments
 
Condensed Consolidated Statements of Cash Flows
 
(in thousands)
 
   
Years Ended December 31,
 
       
2021
 
   
(unaudited)
       
Cash flow from operating activities:
           
Net income
 
$
139,644
   
$
89,315
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
   
90,707
     
99,402
 
Stock-based compensation
   
78,615
     
74,583
 
Disposal gain on sale of business/asset
   
(33,636
)
   
 
Loss from equity-method investees
   
163
     
5,719
 
Deferred income taxes
   
(71,590
)
   
(15,796
)
Net change in operating assets and liabilities
   
(160,939
)
   
(109,724
)
Net cash provided by operating activities
   
42,964
     
143,499
 
                 
Cash flow from investing activities:
               
Acquisitions, net of cash received
   
(72,319
)
   
(223,080
)
Proceeds from sale of assets/business, net of cash divested
   
40,987
     
 
Capital expenditures
   
(48,193
)
   
(40,975
)
Capitalization of internally developed software
   
(388
)
   
(1,463
)
Additions to other intangibles
   
(3,558
)
   
(2,751
)
Acquisitions of equity-method and other investments
   
     
(15,753
)
Sales and maturities of short-term investments
   
     
60,297
 
Net cash used by investing activities
   
(83,471
)
   
(223,725
)
                 
Cash flow from financing activities:
               
Proceeds from term loan
   
500,000
     
 
Payments of term loan
   
(6,250
)
   
(98,750
)
Proceeds from revolving line of credit
   
268,000
     
300,000
 
Payments of revolving line of credit
   
(518,000
)
   
 
Debt issuance costs
   
(2,348
)
   
(1,993
)
Proceeds from issuance of common stock
   
31,815
     
32,518
 
Repurchase of common stock
   
(151,830
)
   
(55,000
)
Dividends paid
   
(147,835
)
   
(143,113
)
Net cash provided by (used by) financing activities
   
(26,448
)
   
33,662
 
                 
Impact of changes in exchange rates on cash
   
(4,352
)
   
(2,562
)
                 
Net change in cash and cash equivalents
   
(71,307
)
   
(49,126
)
Cash and cash equivalents at beginning of period
   
211,106
     
260,232
 
Cash and cash equivalents at end of period
 
$
139,799
   
$
211,106
 

The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related intangibles and fair value adjustments, acquisition-related transaction costs, disposal gains on sale of business/assets and related charitable contributions, tax effects related to businesses held-for-sale, capitalization and amortization of internally developed software costs, and restructuring charges that were recorded in the line items indicated below (unaudited) (in thousands):

   
Three Months Ended
   
Years Ended
 
   
December 31,
     
       
2021
   
2022
   
2021
 
Stock-based compensation
                       
Cost of sales
 
$
884
   
$
1,092
   
$
4,658
   
$
4,580
 
Sales and marketing
   
4,991
     
6,284
     
26,430
     
25,233
 
Research and development
   
6,034
     
5,811
     
24,556
     
23,515
 
General and administrative
   
5,862
     
5,335
     
22,970
     
21,384
 
Provision for income taxes
   
(2,418
)
   
(2,010
)
   
(10,105
)
   
(12,047
)
Total
 
$
15,353
   
$
16,512
   
$
68,509
   
$
62,665
 
                                 
Amortization of acquisition-related intangibles and fair value adjustments
                               
Net sales
 
$
254
   
$
352
   
$
1,367
   
$
2,324
 
Cost of sales
   
5,878
     
6,700
     
22,903
     
19,391
 
Sales and marketing
   
4,955
     
3,334
     
22,379
     
10,192
 
Research and development
   
     
320
     
(320
)
   
320
 
Other expense (income)
   
467
     
531
     
1,968
     
2,007
 
Provision for income taxes
   
(1,705
)
   
(1,626
)
   
(7,507
)
   
(4,071
)
Total
 
$
9,849
   
$
9,611
   
$
40,790
   
$
30,163
 
                                 
Acquisition-related transaction and integration costs, restructuring charges, and other(1)(2)
                               
Net sales
 
$
   
$
   
$
(411
)
 
$
 
Cost of sales
   
1,270
     
25
     
9,819
     
(25
)
Sales and marketing
   
7,014
     
1,687
     
12,478
     
7,759
 
Research and development
   
2,422
     
9,682
     
3,977
     
11,104
 
General and administrative (2)
   
11,068
     
865
     
15,547
     
8,254
 
Gain on sale of asset (2)
   
     
     
(33,636
)
   
 
Other expense (income) (1)
   
(400
)
   
     
(5,685
)
   
4,322
 
Provision for income taxes
   
(4,433
)
   
(2,708
)
   
60
     
(6,837
)
Total
 
$
16,941
   
$
9,551
   
$
2,149
   
$
24,577
 
(1): During the first quarter of 2021, we recognized a $3.5 million impairment loss related to one of our equity-method investments.
 
(2): During the third quarter of 2022, the company recognized a gain of $34 million related to the sale of land and office buildings, presented within "Gain on sale of assets". The company also recognized a charitable contribution expense of $10 million related to an infrequent donation using a portion of the proceeds from the sale of the building, presented within "General and administrative".
 
   
(Capitalization) and amortization of internally developed software costs
                               
Cost of sales
 
$
773
   
$
5,041
   
$
5,863
   
$
23,674
 
Research and development
   
     
(188
)
   
(388
)
   
(1,433
)
Provision for income taxes
   
(179
)
   
(1,085
)
   
(1,238
)
   
(4,877
)
Total
 
$
594
   
$
3,768
   
$
4,237
   
$
17,364
 
                                 

National Instruments
 
Reconciliation of GAAP to Non-GAAP Measures
 
(in thousands, unaudited)
 
 
                       
   
Three Months Ended
   
Years Ended
 
   
December 31,
     
       
2021
   
2022
   
2021
 
Reconciliation of Gross Profit to Non-GAAP Gross Profit
                       
Gross profit, as reported
 
$
303,955
   
$
297,045
   
$
1,122,251
   
$
1,048,718
 
Stock-based compensation
   
884
     
1,092
     
4,658
     
4,580
 
Amortization of acquisition-related intangibles and fair value adjustments
   
6,132
     
7,052
     
24,270
     
21,715
 
Acquisition transaction and integration costs, restructuring charges and other
   
1,270
     
25
     
9,408
   
$
(25
)
Amortization of internally developed software costs
   
773
     
5,041
     
5,863
     
23,674
 
Non-GAAP gross profit
 
$
313,014
   
$
310,255
   
$
1,166,450
   
$
1,098,662
 
Non-GAAP gross margin
   
70%

   
74%

   
70%

   
75%

                                 
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
                 
Operating expenses, as reported
 
$
243,624
   
$
247,148
   
$
963,818
   
$
930,553
 
Stock-based compensation
   
(16,887
)
   
(17,430
)
   
(73,956
)
   
(70,132
)
Amortization of acquisition-related intangibles and fair value adjustments
   
(4,955
)
   
(3,654
)
   
(22,059
)
   
(10,512
)
Acquisition transaction and integration costs, restructuring charges and other
   
(20,504
)
   
(12,234
)
   
(32,002
)
   
(27,117
)
Capitalization of internally developed software costs
   
     
188
     
388
     
1,433
 
Non-GAAP operating expenses
 
$
201,278
   
$
214,018
   
$
836,189
   
$
824,225
 
                                 
Reconciliation of Operating Income to Non-GAAP Operating Income
                 
Operating income, as reported
 
$
60,331
   
$
49,897
   
$
192,069
   
$
118,165
 
Stock-based compensation
   
17,771
     
18,522
     
78,614
     
74,712
 
Amortization of acquisition-related intangibles and fair value adjustments
   
11,087
     
10,706
     
46,329
     
32,227
 
Acquisition transaction and integration costs, restructuring charges and other
   
21,774
     
12,259
     
41,410
     
27,092
 
Net amortization of internally developed software costs
   
773
     
4,853
     
5,475
     
22,241
 
Gain on sale of business/assets
   
     
     
(33,636
)
   
 
Non-GAAP operating income
 
$
111,736
   
$
96,237
   
$
330,261
   
$
274,437
 
Non-GAAP operating margin
   
25%

   
23%

   
20%

   
19%

                                 
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes
                 
Provision for income taxes, as reported(1)
 
$
8,694
   
$
4,822
   
$
32,232
   
$
14,260
 
Stock-based compensation
   
2,418
     
2,010
     
10,105
     
12,047
 
Amortization of acquisition-related intangibles and fair value adjustments
   
1,705
     
1,626
     
7,507
     
4,071
 
Acquisition transaction and integration costs, restructuring charges and other
   
4,433
     
2,708
     
6,378
     
6,837
 
Net amortization of internally developed software costs
   
179
     
1,085
     
1,238
     
4,877
 
Gain on sale of business/assets
   
     
     
(6,438
)
   
 
Non-GAAP provision for income taxes(1)
 
$
17,429
   
$
12,251
   
$
51,022
   
$
42,092
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 


Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS
 
(in thousands, except per share data, unaudited)

 
 
                       
 
 
Three Months Ended
   
Years Ended
 
 
 
December 31,
     
 
     
2021
   
2022
   
2021
 
 
                       
Net income, as reported
 
$
40,066
   
$
40,336
   
$
139,644
   
$
89,315
 
Adjustments to reconcile net income to non-GAAP net income:
                               
Stock-based compensation
   
17,771
     
18,522
     
78,614
     
74,712
 
Amortization of acquisition-related intangibles and fair value adjustments
   
11,554
     
11,237
     
48,297
     
34,234
 
Acquisition transaction and integration costs, restructuring charges and other
   
21,374
     
12,259
     
35,725
     
31,414
 
Net amortization of internally developed software costs
   
773
     
4,853
     
5,475
     
22,241
 
Gain on sale of business/asset
   
     
     
(33,636
)
   
 
Income tax effects and adjustments(1)
   
(8,735
)
   
(7,429
)
   
(18,790
)
   
(27,832
)
Non-GAAP net income
 
$
82,803
   
$
79,778
   
$
255,329
   
$
224,084
 
Non-GAAP net margin
   
18.5%

   
18.9%

   
15.4%

   
15.2%

 
                               
Diluted EPS, as reported
 
$
0.30
   
$
0.30
   
$
1.05
   
$
0.67
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
                               
Stock-based compensation
   
0.14
     
0.14
     
0.59
     
0.56
 
Amortization of acquisition-related intangibles and fair value adjustments
   
0.09
     
0.09
     
0.37
     
0.26
 
Acquisition transaction and integration costs, restructuring charges and other
   
0.16
     
0.09
     
0.27
     
0.23
 
Net amortization of internally developed software costs
   
0.01
     
0.04
     
0.04
     
0.17
 
Gain on sale of business/asset
   
     
     
(0.25
)
   
 
Income tax effects and adjustments(1)
   
(0.07
)
   
(0.06
)
   
(0.14
)
   
(0.21
)
Non-GAAP diluted EPS
 
$
0.63
   
$
0.60
   
$
1.93
   
$
1.68
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 
 
                               
Weighted average shares outstanding
                               
Basic
   
130,842
     
132,215
     
131,738
     
132,311
 
Diluted
   
131,746
     
133,225
     
132,533
     
133,562
 

Reconciliation of GAAP Diluted EPS Guidance to Non-GAAP Diluted EPS Guidance
 
(unaudited)
 
 
 
Three Months Ended
 
 
   
 
           
 
 
Low
   
High
 
GAAP Diluted EPS, guidance
 
$
0.14
   
$
0.28
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
               
Stock-based compensation
   
0.14
     
0.14
 
Amortization of acquisition-related intangibles and fair value adjustments
   
0.08
     
0.08
 
Acquisition transaction and integration costs, restructuring charges and other
   
0.19
     
0.19
 
Net amortization of internally developed software costs
   
     
 
Income tax effects and adjustments(1)
   
(0.07
)
   
(0.07
)
Non-GAAP Diluted EPS, guidance
 
$
0.48
   
$
0.62
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
3/31/23
3/6/23
2/13/23
Filed on / For Period end:1/31/23
12/31/224
9/30/2210-Q
6/30/2210-Q
3/31/2210-Q
12/31/2110-K,  SD
 List all Filings 
Top
Filing Submission 0000935494-23-000004   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 12:43:24.2pm ET